Clinical Schedule Inpatient Moses Medical Liver Service Rotation Monday Tuesday Wednesday Thursday Friday Sat/Sunday 9-12Team Rounds 3-4PMSelection Meeting/QAPI 4PMSignout Rounds 8AMCore/Case Conference 9-12Team Rounds 2PMConsult Rounds 4PMSignout Rounds 8AMJournal Club OR Board Review 9-12Team Rounds 2PMConsult Rounds 4PMSignout Rounds 8AMTumor Board 9-12Team Rounds 2PMContinuity Clinic 4PMSignout Rounds 5PMGI/Liver Grand Rounds 8AMPathology OR Guideline Confernce 9-12Team Rounds 2PMConsult Rounds 4PMSignout Rounds On Call:9-12Team Rounds Consult/Outpatient Service Schedule Monday Tuesday Wednesday Thursday Friday Sat/Sunday 9-12Transplant Clinic 3-4PMSelection Meeting/QAPI 8AMCore/Case Conference 9-12Transplant Clinic 2PMConsult Rounds 8AMJournal Club OR Board Review 9-12Transplant Clinic 2PMConsult Rounds 8AMTumor Board 9-12Consult Rounds 1PMContinuity Clinic 5PMGI/Liver Grand Rounds 8AMPathology OR Guidelines Confernce 9-12Transplant Clinic 2PMConsult Rounds On Call: 9-12Team Rounds Fellows may attend specialty office hours, including hepatology, oncology, hepatobiliary surgery, and pediatric liver transplant clinics. Call Schedule Hepatology fellows cover two weekend days per month. Additionally, overnight call coverage is shared between hepatology and gastroenterology fellows. The hepatology fellow will take call two nights per week, only covering the inpatient hepatology service, including any incoming admissions or transfers. Research All hepatology fellows are encouraged early in their training to identify a project of interest. With a large faculty with diverse research interests available, they will work closely with a research mentor to develop a project with the goal of presenting at a national meeting and publishing in a respected journal. Recent Publications by Montefiore Fellows & Faculty Díaz LA, Fuentes-López E, Ayares G, Idalsoaga F, Arnold J, Valverde MA, Perez D, Gómez J, Escarate R, Villalón A, Ramírez CA, Hernandez-Tejero M, Zhang W, Qian S, Simonetto DA, Ahn JC, Buryska S, Dunn W, Mehta H, Agrawal R, Cabezas J, García-Carrera I, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de-la-Tijera F, Kulkarni AV, Rao PN, Salazar PG, Skladaný L, Bystrianska N, Clemente-Sanchez A, Villaseca-Gómez C, Haider T, Chacko KR, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Marciano S, Dirchwolf M, Vargas V, Jiménez C, Louvet A, García-Tsao G, Roblero JP, Abraldes JG, Shah VH, Kamath PS, Arrese M, Singal AK, Bataller R, Arab JP. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis. JHEP Rep. 2023 Mar 15;5(8):100727. doi: 10.1016/j.jhepr.2023.100727. PMID: 37456675; PMCID: PMC10339256. Bteich F, Desai K, Zhang C, Kaur A, Levy RA, Bioh L, Wang A, Sultana S, Kaubisch A, Kinkhabwala M, Bellemare S, Fidvi S, Kanmaniraja D, Berkenblit R, Moon JY, Adedimeji A, Tow CY, Saenger Y. Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States. J Hepatocell Carcinoma. 2024 Feb 3;11:257-269. doi: 10.2147/JHC.S436804. PMID: 38333221; PMCID: PMC10849901. Nahas J, Tow CY, Chacko KR, Haider T, Massoumi H. Granulocyte colony-stimulating factor does not improve mortality in severe alcoholic hepatitis: a single-center experience from the United States. Gastroenterol Hepatol Bed Bench. 2023;16(1):524-526. doi: 10.22037/ghfbb.v16i1.2639. PMID: 37070107; PMCID: PMC10105506. Kaplan DE, Ripoll C, Thiele M, Fortune BE, Simonetto DA, Garcia-Tsao G, Bosch J. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology. 2023 Oct 23. doi: 10.1097/HEP.0000000000000647. Epub ahead of print. PMID: 37870298. Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Garcia-Tsao G, Hall SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB; Advancing Liver Therapeutic Approaches (ALTA) Consortium. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36. doi: 10.1016/j.cgh.2021.07.018. Epub 2021 Jul 15. PMID: 34274511; PMCID: PMC8760361. Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, Rıza Calışkan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batıbay E, Urzua Á, Snijders R, Kıyıcı M, Akyıldız M, Ekin N, Carr RM, Harputluoğlu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Björnsson E, Boyer JL, Invernizzi P, Levy C, Schiano TD, Ridruejo E, Wahlin S. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study. Hepatology. 2021 Jun;73(6):2099-2109. PMID: 33713486; PMCID: PMC8250536. Andacoglu O, Özbek U, Liu J, Figueredo C, Chacko KR, Tow C, Reinus JF, Kinkhabwala M. Comparison of 1-Year Morbidity Following Liver Transplant for Acute Alcoholic Hepatitis Versus Alcoholic Cirrhosis. Exp Clin Transplant. 2021 May;19(5):439-444. Epub 2021 Jan 11. PMID: 33455569. Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Garcia-Tsao G, Hall SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB; Advancing Liver Therapeutic Approaches (ALTA) Consortium. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. Clin Gastroenterol Hepatol. 2021 Jul 15:S1542-3565(21)00749-7. PMID: 34274511; PMCID: PMC8760361. Frager SZ, Schwartz JM. Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve. Curr Oncol. 2020 Nov;27(Suppl 3):S138-S143. PMID: 33343207; PMCID: PMC7739519.